Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

ABUS — Arbutus Biopharma Corporation

UNDERVALUED (MOS Model unreliable) · Quality 55/100

Value Score 30 days ago: 44.4 → today 46.1

ABUS - Arbutus Biopharma Corporation
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 3.88 USD
Intrinsic value: 13.96 USD
Margin of safety: Model unreliable
Valuation: UNDERVALUED
Value Score: 46.1
Quality: 55/100
Moat score: 16 (erosion: none)
UNDERVALUED (MOS Model unreliable) - Quality 55/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/ABUS
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

3.88

Intrinsic value

13.96

Margin of safety

Model unreliable

Implied growth (reverse DCF)

a described calculation from stated inputs, not a forecast

Value Score

46.1

Quality

Psychology

25.5

Discovery

8.6

price/volume attention only

Moat score

erosion: none

Value Score: top 8% of Russell 3000 · Quality: top 48%

Open the interactive Deep Dive for ABUS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ABUS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ABUS undervalued?

As of 2026-11-11, ABUS trades at 3.88 against a computed intrinsic value of 13.96 (+72.2% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Arbutus Biopharma Corporation's Value Score?

Arbutus Biopharma Corporation's Value Score is 46.1 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.